Amendment reduces and simplifies royalty structure on Teverelix ® from ~4% to 2% while preserving global rights and IP control The Company is ...

It is crucial to understand the drug development process and the many milestones and tasks that are essential to a comprehensive development plan to guarantee scientific and commercial success. While ...

The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...

The market size of CGT products is expected to continue to rise by 2031 and reach $63 billion. CGTs have yielded commercial gains for several pharma companies. For example, some of the top-selling CGT ...

Bioprocessing is an umbrella term that describes the research, development, manufacturing, and commercialization of products derived from or used by biological systems. For industrial purposes, ...

The global pharmaceutical industry is witnessing a steady transformation as plant-based active pharmaceutical ingredients (APIs) move from complementary roles toward becoming core components in modern ...

DOVER, DE, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- The safety of parenteral medicines and medical devices ...

Pharmaceutical brands are gaining celebrity status, impacting consumer demand and market dynamics, with corporate identity becoming a key competitive advantage as innovation cycles shorten. Trust in ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

Jan 2026CEO of family company Angelini Industries will also lead the pharmaceutical company from today, bringing strong leadership experience and strategic visionRome (Italy), 12/01/2026 – Angelini ...